Health & Fitness
Health and Fitness
Health and Fitness
Thu, September 9, 2010
Wed, September 8, 2010
The Briscoe Law Firm Investigates ZymoGenetics Inc.a?s Board Concerning the Acquisition of ZymoGenetics by Bristol-Myers Squibb
DALLAS--([ BUSINESS WIRE ])--[ The Briscoe Law Firm, PLLC ], founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the law firm of Powers Taylor, LLP are investigating potential legal claims against the Board of Directors of [ ZymoGenetics Inc ]. (aZGENa or aCompanya) (NASDAQ: ZGEN) related to the proposed acquisition of the ZymoGenetics by [ Bristol-Myers Squibb Company ].
The agreement involves a transaction valued at approximately $885 million, under which ZymoGenetics shareholders will receive $9.75 in cash for each share ofZGEN common stock they hold. The investigation relates to possible breaches of fiduciary duty and other violations of state law by the Board of Directors of ZGEN for approving this transaction, whether the consideration to be received by ZGEN shareholders is fair, and whether ZGENa™s board of Directors acted in the shareholdersa™ best interests.
If you currently own shares of ZymoGenetics / ZGEN and would like additional information regarding this investigation, or if you have information regarding the allegations involving this transaction, please contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at [ patrick@powerstaylor.com ], or Willie Briscoe at The Briscoe Law Firm, PLLC toll free (877) 397-5991, or via email at [ WBriscoe@TheBriscoeLawFirm.com ]. There is no cost or fee to you.
The Briscoe Law Firm is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.
Powers Taylor, LLP is a boutique litigation law firm that handles a variety of shareholder litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.
